ATE81982T1 - Verwendung von vollsynthetischem alpha-hanap. - Google Patents
Verwendung von vollsynthetischem alpha-hanap.Info
- Publication number
- ATE81982T1 ATE81982T1 AT85110985T AT85110985T ATE81982T1 AT E81982 T1 ATE81982 T1 AT E81982T1 AT 85110985 T AT85110985 T AT 85110985T AT 85110985 T AT85110985 T AT 85110985T AT E81982 T1 ATE81982 T1 AT E81982T1
- Authority
- AT
- Austria
- Prior art keywords
- hanap
- fully synthetic
- alpha
- disregulation
- synthetic alpha
- Prior art date
Links
- 101000780028 Homo sapiens Natriuretic peptides A Proteins 0.000 abstract 2
- 102000056614 human NPPA Human genes 0.000 abstract 2
- 206010003445 Ascites Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 206010041277 Sodium retention Diseases 0.000 abstract 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
- 108010004977 Vasopressins Proteins 0.000 abstract 1
- 102000002852 Vasopressins Human genes 0.000 abstract 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 230000000506 psychotropic effect Effects 0.000 abstract 1
- 229960003726 vasopressin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843443257 DE3443257A1 (de) | 1984-11-28 | 1984-11-28 | Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap) |
| EP85110985A EP0182984B1 (de) | 1984-11-28 | 1985-08-30 | Verwendung von vollsynthetischem alpha-hANap |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE81982T1 true ATE81982T1 (de) | 1992-11-15 |
Family
ID=6251299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85110985T ATE81982T1 (de) | 1984-11-28 | 1985-08-30 | Verwendung von vollsynthetischem alpha-hanap. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0182984B1 (de) |
| JP (1) | JPS61130236A (de) |
| AT (1) | ATE81982T1 (de) |
| DE (2) | DE3443257A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60136596A (ja) * | 1983-12-26 | 1985-07-20 | Suntory Ltd | ペプチド及びこれを有効成分とする利尿剤 |
| US5159061A (en) * | 1986-09-29 | 1992-10-27 | Takeda Chemical Industries, Ltd. | Atrial natriuretic peptide derivative |
| DE3878231T2 (de) * | 1987-03-02 | 1993-05-27 | Bissendorf Peptide Gmbh | Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. |
| IL85728A (en) * | 1987-03-25 | 1993-01-14 | Bio Mega Inc | Fluorine containing atrial natriuretic peptides, their preparation and pharmaceutical compositions containing them |
| DE3737917A1 (de) * | 1987-11-07 | 1989-05-18 | Bissendorf Peptide Gmbh | Phosphorylierte derivate von cardiodilatin/anf-peptiden |
| US5461142A (en) * | 1987-11-07 | 1995-10-24 | Pharma Bissendorf Peptide Gmbh | Phosphorylated derivatives of cardiodilatin/ANF peptides |
| JP2925391B2 (ja) * | 1992-01-09 | 1999-07-28 | サントリー株式会社 | Ａｒｄｓ治療用医薬組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0116784B1 (de) * | 1982-02-22 | 1992-06-10 | Queen's University At Kingston | Atrial natriuretischer Faktor |
| JPS60136596A (ja) * | 1983-12-26 | 1985-07-20 | Suntory Ltd | ペプチド及びこれを有効成分とする利尿剤 |
| US4851349A (en) * | 1984-04-12 | 1989-07-25 | Mitsubishi Chemical Industries Limited | Expression vectors encoding cardionatrin and cardiodilatin |
| DE3588006T2 (de) * | 1984-04-19 | 1995-08-10 | Scios Nova Inc | Atrielle natriumuretische/gefässerweiterende polypeptide. |
-
1984
- 1984-11-28 DE DE19843443257 patent/DE3443257A1/de not_active Ceased
-
1985
- 1985-08-30 DE DE8585110985T patent/DE3586793T2/de not_active Expired - Fee Related
- 1985-08-30 EP EP85110985A patent/EP0182984B1/de not_active Expired - Lifetime
- 1985-08-30 AT AT85110985T patent/ATE81982T1/de active
- 1985-09-11 JP JP60202503A patent/JPS61130236A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61130236A (ja) | 1986-06-18 |
| EP0182984B1 (de) | 1992-11-04 |
| EP0182984A3 (en) | 1987-06-16 |
| DE3443257A1 (de) | 1986-05-28 |
| EP0182984A2 (de) | 1986-06-04 |
| DE3586793D1 (de) | 1992-12-10 |
| DE3586793T2 (de) | 1993-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE76309T1 (de) | Dialyseloesung und ihre herstellung unter verwendung von peptiden auf der basis von glycin. | |
| DE3576139D1 (de) | Volltextil-kompositgewebe. | |
| ES528649A0 (es) | Un polipeptido sintetico | |
| DE3661849D1 (en) | Textile reinforcing layer useful in the manufacture of laminated articles, and laminated articles containing such a reinforcing layer | |
| ES2155052T3 (es) | Suela correctora para zapatos, que utiliza un contorno mayor que el plano de estabilidad tecnico ideal. | |
| DE3853265D1 (de) | Reduzierung der logischen Weglänge unter Verwendung von Boolescher Minimierung. | |
| ATE81982T1 (de) | Verwendung von vollsynthetischem alpha-hanap. | |
| SE8500421D0 (sv) | Collagen-coated synthetic vascular graft | |
| IT8383469A0 (it) | Perfezionamenti ai giuntafili per la giunzione meccanica di fili tessili e giuntafili meccanico adottante tali perfezionamenti. | |
| DE3587925D1 (de) | Verwendung von sulfonierten 2-(2'-hydroxyaryl)-s-triazinen als lichtstabilisierungsmittel für walle oder sonstige proteinfasern. | |
| DE3484584D1 (de) | Injektionen mit verzoegerter abgabe. | |
| DE3684591D1 (de) | Halbleiteranordnung mit flachem uebergang mit autopassiviertem rand. | |
| ATE81345T1 (de) | Synthetische atriale peptide. | |
| IT8419142A0 (it) | Analoghi retro-invertiti esapeptidici c-terminali della sostanza p. | |
| IT8505221A0 (it) | Perfezionamenti ai dispositivi di giunzione per vincolare i tessuti sovrapposti di indumenti o articoli con essi confezionati. | |
| DE69031032D1 (de) | Filter mit einer gleichmässigen abgabe von teer | |
| EP0212912A3 (de) | Calcitonin-Analoga mit C-terminalen D-Aminosäurensubstituenten | |
| DK110585A (da) | Insulinforstaerkende peptider | |
| KR910009271A (ko) | 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료 | |
| ATE122048T1 (de) | Alpha-kristalle von natriumcefanolin. | |
| ATE84071T1 (de) | Schweinepankreas-elastase. | |
| DE3665395D1 (en) | Shoe provided with an insole and an inlay of resilient material | |
| DE3780601D1 (de) | Elektronischer rechner mit verwendung von konstanten. | |
| ES278750U (es) | Tobera para aspiradora de polvo | |
| ATE50535T1 (de) | Volltextil-kompositgewebe. |